These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease. Majewski S; Tworek D; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Brzeziańska-Lasota E; Jerczyńska H; Antczak A; Piotrowski WJ; Górski P Int J Chron Obstruct Pulmon Dis; 2019; 14():1611-1631. PubMed ID: 31413557 [TBL] [Abstract][Full Text] [Related]
4. Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo. Kunz LI; van't Wout EF; van Schadewijk A; Postma DS; Kerstjens HA; Sterk PJ; Hiemstra PS Respir Res; 2015 Dec; 16():154. PubMed ID: 26696093 [TBL] [Abstract][Full Text] [Related]
5. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
6. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. Létuvé S; Kozhich A; Arouche N; Grandsaigne M; Reed J; Dombret MC; Kiener PA; Aubier M; Coyle AJ; Pretolani M J Immunol; 2008 Oct; 181(7):5167-73. PubMed ID: 18802121 [TBL] [Abstract][Full Text] [Related]
7. The relation of circulating YKL-40 to levels and decline of lung function in adult life. Guerra S; Halonen M; Sherrill DL; Venker C; Spangenberg A; Carsin AE; Tarès L; Lavi I; Barreiro E; Martínez-Moratalla J; Urrutia I; Sunyer J; Antó JM; Martinez FD Respir Med; 2013 Dec; 107(12):1923-30. PubMed ID: 23920328 [TBL] [Abstract][Full Text] [Related]
8. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease]. Cheng Z; Kang Y; Wu QG; Dai LL; Song YN; Xia J; Si JM; Chen CY Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):2981-4. PubMed ID: 22333024 [TBL] [Abstract][Full Text] [Related]
9. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Hou C; Zhao H; Liu L; Li W; Zhou X; Lv Y; Shen X; Liang Z; Cai S; Zou F Mol Med; 2011; 17(7-8):807-15. PubMed ID: 21380479 [TBL] [Abstract][Full Text] [Related]
10. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap]. Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121 [TBL] [Abstract][Full Text] [Related]
11. YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma. Lee JH; Park KH; Park JW; Hong CS J Investig Allergol Clin Immunol; 2012; 22(7):501-7. PubMed ID: 23397672 [TBL] [Abstract][Full Text] [Related]
12. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease. Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648 [TBL] [Abstract][Full Text] [Related]
13. Pentraxin 3 sputum levels differ in patients with chronic obstructive pulmonary disease vs asthma. Schwingel FL; Pizzichini E; Kleveston T; Morato EF; Pinheiro JT; Steidle LJ; Dal-Pizzol F; Rocha CC; Pizzichini MM Ann Allergy Asthma Immunol; 2015 Dec; 115(6):485-9. PubMed ID: 26508705 [TBL] [Abstract][Full Text] [Related]
14. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease]. Chen Y; Chen P Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313 [TBL] [Abstract][Full Text] [Related]
15. High serum YKL-40 level in patients with COPD is related to hypoxemia and disease severity. Gumus A; Kayhan S; Cinarka H; Kirbas A; Bulmus N; Yavuz A; Sahin U; Ozkaya S Tohoku J Exp Med; 2013 Feb; 229(2):163-70. PubMed ID: 23364142 [TBL] [Abstract][Full Text] [Related]